S68587 - 20 megaCells/ml, S68587 - 15 megaCells/ml, S68587 - 6 megaCells/ml, S68587 - 0.6 megaCells/ml clinical trials

Long-term follow-up study of patients who have previously been exposed to UCART19 (allogeneic engineered T-cells expressing a lentiviral-based anti-CD19 chimeric antigen receptor)

This study is checking on the long-term health of people, including children, who have previously received a special treatment called UCART19 for advanced leukaemia. Researchers want to understand if there are any side effects over time and how patients are doing generally after treatment.